TipRanks
Valion Bio (VBIO)
NASDAQ:VBIO
US Market
Want to see VBIO full AI Analyst Report?

Valion Bio (VBIO) Financial Statements

172 Followers

Valion Bio Financial Overview

Valion Bio's market cap is currently $2.11M. The company's EPS TTM is $-56.74; its P/E ratio is -0.04; Valion Bio is scheduled to report earnings on August 17, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 24Dec 23Mar 23
Income Statement
Total Revenue$ 0.00$ 1.18M$ 0.00$ 1.84M$ 1.26M
Gross Profit$ 0.00$ 287.00K$ -352.00K$ 299.00K$ -46.00K
Operating Income$ -7.90M$ -8.24M$ -4.42M$ -10.10M$ -5.63M
EBITDA$ -7.84M$ -8.06M$ -4.06M$ -9.92M$ -5.61M
Net Income$ -8.88M$ -8.24M$ -5.66M$ -10.10M$ -8.49M
Balance Sheet
Cash & Short-Term Investments$ 12.64M$ 3.40M$ 2.00M$ 3.52M$ 12.97M
Total Assets$ 31.61M$ 5.16M$ 2.81M$ 5.88M$ 15.04M
Total Debt$ 6.45M$ 369.00K$ 0.00$ 530.00K$ 708.00K
Net Debt$ -6.19M$ -3.03M$ -2.00M$ -2.99M$ -12.27M
Total Liabilities$ 14.81M$ 1.58M$ 272.00K$ 2.25M$ 1.76M
Stockholders' Equity$ 16.80M$ 3.58M$ 2.54M$ 3.63M$ 13.27M
Cash Flow
Free Cash Flow$ -7.04M$ -8.63M$ -5.72M$ -8.93M$ -5.61M
Operating Cash Flow$ -7.00M$ -8.51M$ -5.72M$ -8.92M$ -5.61M
Investing Cash Flow$ -705.00K$ -118.00K$ 0.00$ -11.00K$ 0.00
Financing Cash Flow$ 18.35M$ 8.51M$ 4.33M$ -528.00K$ 17.54M
Currency in USD

Valion Bio Earnings and Revenue History

Valion Bio Debt to Assets

Valion Bio Cash Flow

Valion Bio Forecast EPS vs Actual EPS